Cargando…

Impact of myeloperoxidase dosage in acute coronary syndrome

Detalles Bibliográficos
Autores principales:	Esporcatte, R, Rey, HCV, Rocha, RM, Bittencourt, MI, Salgado, CS, Garcia, MI, Potsch, A, Marins, ALC, Dohmann, HFR, Mendonça, HTF, Rangel, FOD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097481/ http://dx.doi.org/10.1186/cc3574

Ejemplares similares

B-type natriuretic peptide as a risk predictor of long-term outcomes in heart failure patients
por: Rey, HCV, et al.
Publicado: (2005)

Prediction of heart failure by C-reactive protein in patients with acute myocardial infarction
por: Rangel, FOD, et al.
Publicado: (2005)

Validation of the ADHERE model for risk stratification in patients with acute heart failure admitted to the critical care unit
por: Rey, HCV, et al.
Publicado: (2005)

Influence of renal dysfunction on inhospital morbidity and mortality of patients with decompensated heart failure
por: Rocha, RM, et al.
Publicado: (2005)

Obesity and inhospital prognosis in acute heart failure
por: Ferreira, FAC, et al.
Publicado: (2005)

Prognostic value of D-dimer in acute heart failure
por: Bittencourt, MI, et al.
Publicado: (2005)

Is anemia a predictor of inhospital complications and mortality in decompensated heart failure?
por: Rocha, RM, et al.
Publicado: (2005)

Use of anticoagulation and D-dimer levels in patients with acute heart failure
por: Bittencourt, MI, et al.
Publicado: (2005)

Age-related trends in prehospital delay time interval and reperfusion therapy in patients with ST elevation acute myocardial infarction
por: Rangel, FOD, et al.
Publicado: (2001)

Comparison of monophasic versus biphasic cardioversion for atrial fibrillation
por: Vaisman, M, et al.
Publicado: (2005)

Aggressive therapy for non-ST elevation acute coronary syndromes is highly effective
por: Santos, RA, et al.
Publicado: (2001)

Hemorrhagic complications during percutaneous coronary interventions: prospective analysis of 270 cases
por: Kanto, MCFS, et al.
Publicado: (2001)

A prospective analysis of complications related to the use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
por: Rocha, RM, et al.
Publicado: (2001)

Long-term prognostic value of C-reactive protein in unstable angina
por: Mesquita, CT, et al.
Publicado: (2001)

Macrophage chemoattractant protein 1 and outcome in cardiopulmonary bypass
por: Pereira, KC, et al.
Publicado: (2005)

Features and markers of mortality of hospital patients that use intra-aortic balloon pump
por: Porto, AD, et al.
Publicado: (2001)

Macrophage migration inhibitory factor (MIF), C-reactive protein (CRP) and C3a serum levels following coronary artery bypass graft surgery (CABG)
por: Mendonça F°, HTF, et al.
Publicado: (2001)

Clinical improvement after autologous bone marrow mononuclear cell transplantation
por: Dohmann, HF, et al.
Publicado: (2003)

Acute atrial fibrillation (AAF) in cardiac surgery postoperative period: evaluation of preoperative and peroperative factors associated with its higher incidence
por: Aranha, FG, et al.
Publicado: (2002)

Predictors of hospital costs in patients submitted to heart surgery: the intensivist point of view
por: Gomes, RV, et al.
Publicado: (2002)

Immediate postoperative thoracic epidural analgesia following heart surgery: a comparative analysis of patient-controlled continuous thoracic epidural analgesia (PCCTEA) versus intermittent thoracic epidural analgesia (ITEA)
por: Campos, LA, et al.
Publicado: (2001)

Markers of length of stay in surgical intensive care unit, in patients submitted to heart surgery
por: Gomes, RV, et al.
Publicado: (2001)

Features and markers of nosocomial pneumonia in patients undergoing heart surgery
por: Morgado, JV, et al.
Publicado: (2001)

Early prediction of mechanical ventilation length of stay (MV-LOS) forpatients submitted to heart surgery
por: Mendonça F°, HTF, et al.
Publicado: (2001)

Early experience of intensive postoperative unit (IPU): percutaneous tracheotomy as the first option after long-term oro-tracheal intubation
por: Azevedo F°, CF, et al.
Publicado: (2001)

Macrophage migration inhibitory factor as a diagnostic tool for acute coronary syndrome
por: Pereira, KC, et al.
Publicado: (2005)

Transendocardial, autologous bone-marrow cell transplant in severe, chronic ischemic heart failure
por: Dohman, HF, et al.
Publicado: (2003)

Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis
por: Wang, Yan, et al.
Publicado: (2017)

Myeloperoxidase is not a good biomarker for preeclampsia prediction
por: Rocha-Penha, L., et al.
Publicado: (2017)

Myeloperoxidase in Health and Disease
por: Ortiz-Cerda, Tamara, et al.
Publicado: (2023)

Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease
por: Zhong, Chen, et al.
Publicado: (2009)

Association between myeloperoxidase rs2333227 polymorphism and susceptibility to coronary heart disease
por: Zhang, Yi-Qing, et al.
Publicado: (2020)

The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture
por: Teng, Nathaniel, et al.
Publicado: (2016)

Evaluation of platelet activity by multiple electrode impedance aggregometry in acute coronary syndromes: pilot study in a Brazilian tertiary-care public hospital
por: De Lorenzo, A., et al.
Publicado: (2019)

Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes
por: Loria, Valentina, et al.
Publicado: (2008)

Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques
por: Tavora, Fabio R, et al.
Publicado: (2009)

Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography—The LURIC study
por: Scharnagl, Hubert, et al.
Publicado: (2014)

Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease
por: MAYYAS, FADIA A., et al.
Publicado: (2014)

Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease
por: Kimak, Elżbieta, et al.
Publicado: (2018)

A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients
por: Khalilova, Irada S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qq5a9v5nudb6n1gggbfebvkes6